 |
|
IndapamideEffects on Apoprotein, Lipoprotein, and Glucoregulation in Ambulatory Diabetic Patients
Kwame Osei, MD;
Greg Holland;
James M. Falko, MD
Arch Intern Med. 1986;146(10):1973-1977.
Abstract
| |
• We evaluated the long-term effects of indapamide, a nonthiazide diuretic, on blood pressure, glucoregulation, free insulin and C-peptide levels, and lipoprotein and apoprotein metabolism in 13 hypertensive diabetic patients for 24 weeks. Indapamide significantly reduced both systolic and diastolic blood pressure by 15% and 17%, respectively. Both mean fasting serum glucose and integrated glucose responses after oral glucose load (75 g) were significantly higher during indapamide therapy than at week 0. The mean fasting and stimulated C-peptide responses were significantly increased despite worsening glucose control. At the end of 24 weeks, mean glycosylated hemoglobin level had increased significantly. Indapamide caused a slight but insignificant rise in the total triglyceride, cholesterol, and low-density lipoprotein cholesterol levels, while the high-density lipoprotein cholesterol level decreased. In addition, the apoprotein A-1 concentrations remained unchanged while the apoprotein B-100 level decreased. Apart from hypokalemia (<3.5 mEq/L [<3.5 mmol/L]) in three patients that required oral potassium supplementation, biochemical changes were of no clinical consequence.
(Arch Intern Med 1986;146:1973-1977)
Author Affiliations
From the Division of Endocrinology and Metabolism, Department of Medicine, Ohio State University Hospital, Columbus.
Footnotes
Accepted for publication Jan 2, 1986.
Reprint requests to N-1120 Doan Hall, Ohio State University Medical Center, Columbus, OH 43210 (Dr Osei).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide
Nikas et al.
Journal of Renin-Angiotensin-Aldosterone System 2000;1:289-291.
ABSTRACT
|
